Neuberger Berman Group LLC Cytosorbents Corp Transaction History

Neuberger Berman Group LLC

$130 Billion
Q3 2025

A detailed history of Neuberger Berman Group LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,597,998 shares of CTSO stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,597,998

Previous 1,591,689 0.4%

Holding current value

$1.12 Million

Previous $2.04 Million 27.05%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$0.84 - $1.28 $5,299 - $8,075	6,309 Added 0.4%	1,597,998 $1.49 Million
Q2 2025 Aug 13, 2025	SELL	$0.81 - $1.28 $71,230 - $112,561	-87,939 Reduced 5.24%	1,591,689 $2.04 Million
Q1 2025 May 13, 2025	SELL	$0.89 - $1.3 $2,006 - $2,931	-2,255 Reduced 0.13%	1,679,628 $1.68 Million
Q4 2024 Feb 13, 2025	SELL	$0.74 - $1.35 $73,612 - $134,293	-99,477 Reduced 5.58%	1,681,883 $1.51 Million
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.55 $171,392 - $379,511	244,846 Added 15.94%	1,781,360 $2.67 Million
Q2 2024 Nov 14, 2024	SELL	$0.7 - $1.01 $263,236 - $379,812	-376,052 Reduced 19.66%	1,536,514 $1.08 Million
Q2 2024 Aug 13, 2024	SELL	$0.7 - $1.01 $263,236 - $379,812	-376,052 Reduced 19.66%	1,536,514 $1.08 Million
Q1 2024 Nov 14, 2024	BUY	$0.86 - $1.07 $95,259 - $118,520	110,767 Added 6.15%	1,912,566 $1.82 Million
Q1 2024 May 13, 2024	BUY	$0.86 - $1.07 $1.64 Million - $2.05 Million	1,912,566 New	1,912,566 $1.82 Million
Q4 2023 Nov 14, 2024	BUY	$1.08 - $1.94 $286,507 - $514,652	265,285 Added 17.27%	1,801,799 $2 Million
Q4 2023 Feb 09, 2024	BUY	$1.08 - $1.94 $323,031 - $580,259	299,103 Added 19.9%	1,801,799 $2 Million
Q3 2023 Nov 14, 2023	BUY	$1.86 - $4.03 $26,134 - $56,625	14,051 Added 0.94%	1,502,696 $2.83 Million
Q2 2023 Aug 11, 2023	SELL	$2.37 - $3.65 $140,488 - $216,364	-59,278 Reduced 3.83%	1,488,645 $5.34 Million
Q1 2023 May 12, 2023	BUY	$1.79 - $4.17 $33,702 - $78,512	18,828 Added 1.23%	1,547,923 $5.22 Million
Q4 2022 Feb 13, 2023	BUY	$1.03 - $2.03 $51,010 - $100,535	49,525 Added 3.35%	1,529,095 $2.37 Million
Q3 2022 Nov 15, 2022	BUY	$1.2 - $2.46 $181,560 - $372,198	151,300 Added 11.39%	1,479,570 $2 Million
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $134,566 - $246,194	76,458 Added 6.11%	1,328,270 $2.92 Million
Q1 2022 May 13, 2022	SELL	$2.88 - $4.23 $12,257 - $18,002	-4,256 Reduced 0.34%	1,251,812 $3.98 Million
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $18,249 - $36,543	-4,506 Reduced 0.36%	1,256,068 $5.26 Million
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $2.89 Million - $4.01 Million	413,485 Added 48.81%	1,260,574 $10.2 Million
Q2 2021 Aug 13, 2021	SELL	$7.55 - $9.42 $126,273 - $157,549	-16,725 Reduced 1.94%	847,089 $6.39 Million
Q1 2021 May 13, 2021	SELL	$8.23 - $11.48 $406,027 - $566,365	-49,335 Reduced 5.4%	863,814 $7.47 Million
Q4 2020 Feb 10, 2021	BUY	$7.65 - $8.98 $2.53 Million - $2.97 Million	330,555 Added 56.74%	913,149 $7.27 Million
Q3 2020 Nov 12, 2020	BUY	$7.37 - $11.54 $4.29 Million - $6.72 Million	582,594 New	582,594 $4.64 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $30.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Cytosorbents Corp Transaction History